The delayed intervention group was to benefit from the intervention after week 8.

Chikungunya Virus Infection

The wait-list group benefit from a 8-week yoga program after the interventional group

Wait-list group

During 8 weeks, the intervention group attended weekly yoga sessions and had to practice poses at home

Yoga group

Mouffias' Medical Center in Guadeloupe.

Yoga for Chronic Chikungunya

Impact of Yoga on Quality of Life in Patients With Chronic Chikungunya: A Randomized Controlled Study

This scale measures eight health domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) of quality of life for adults aged 18 and older. Using a scoring algorithm, the aggregated scores can provide two summary scores: the physical component summary (PCS) score and the mental component summary (MCS) score.

The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patient is asked to mark their current pain level on the line. They can also be asked to mark their maximum, minimum, and average pain. The examiner scores the VAS by measuring the distance in either centimeters (0 to 10) or millimeters (0 to 100) from the "no pain" anchor point.

The total score is calculated as the sum of the 10 items and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10.

Centre Hospitalier Universitaire de Pointe-a-Pitre

Inflammatory Back Pain

The investigators will evaluate the effect of a gluten free diet (GFD) in IBP patients, randomly assigned to receive standard therapy for IBP or standard therapy for IBP plus GFD, for a period of at least one year.

Gluten free diet

Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca

Department of Internal Medicine, University Hospital of Palermo

Inflammatory Back Pain and Gluten Free Diet

Musculoskeletal (back pain) evaluation, from baseline at 12 months of GFD, according to the scores calculated on the basis of Visual Analogue Scales for Musculoskeletal (back pain), taking into account whether the patients adhered or not to the GFD.

Changes in cytokines production from peripheral blood mononuclear (PBMC), from baseline (i.e. at diagnosis) at 12 months of GFD, taking into account whether the patients adhered or not to the GFD.

Prevalence of IBP in CD and in NCWS patients.

Pasquale Mansueto

University of Palermo

Spinal Surgery

Pain

Tel Aviv Medical Center

Assessment of Central Pain in Patients Who Undergo Spinal Surgery and Influence in Surgery Outcome

evaluation of course of surgery, use of analgesics medications, report of pain intensity, length of hospital stay, questionnaires of health status and functionnal index, physical examination and dolorimetric evaluation

Jacob Ablin

Tel-Aviv Sourasky Medical Center

Open-label treatment with etanercept 50 mg/week subcutaneous injection

Etanercept

Sex: Female, Male

Race (NIH/OMB)

The DLQI is a dermatology-specific health-related quality of life measure. The effect on a patient's life is as follows: 0-1=none; 2-5=small; 6-10=moderate; 11-20=very large; and 21-30=extremely large

Dermatology Life Quality Index (DLQI)

PGA score on a 100 mm visual analog scale, with 0 mm corresponding to no active disease and 100 mm corresponding to very severe disease with multiple, painful inflammatory lesions.

Physician's Global Assessment Score (PGA)

numbers of lesions (nodules and abscesses) as assessed by a physician

No. of lesions

Patient self-report of pain on a 100-mm visual analog scale with 0 corresponding to no pain and 100 mm corresponding to severe pain

Patient Pain Score

Duration of time patient had hidradenitis suppurativa prior to trial (in years)

Duration of disease

Prior systemic and intralesional therapies

A physician assessed number of lesions as baseline and week 12. Responders were defined as those achieving at least a 50% reduction in number of lesions. A response rate was calculated as percentage of patients classified as responders.

50% Reduction in Number of Lesions (Percent of Participants)

Efficacy was measured using the Physician Global Assessment (PGA). Responders were classified as those achieving at least a 50% reduction on the Physician Global Assessment score at week 12 compared with baseline. A response rate was calculated as the percentage of patients that were classified as responders at 12-weeks.
PGA was scored at baseline and at 12 weeks on a 100-mm visual analog scale, with 0 indicating no disease and 100-mm indicating severe disease.

50% Reduction in Physician's Global Assessment Score (Percent of Participants)

The Patient Global Assessment asked patients to rate the extent of hidradenitis activity compared to when the patient started treatment with etanercept (day 0 of study). The scale included a selection of:
Much worse than before treatment Moderately worse (about 50% more disease activity) A little worse Same A little improved Moderately improved (about 50% reduction in disease activity) Much better than before treatment (no active disease or almost no active disease)

Patient Global Assessment

Patient's were asked to self-report their pain on a 100-mm visual analog scale (with 0 corresponding to no pain and 100 mm corresponding to severe pain). Responders were defined as those achieving at least a 50% reduction in pain score from baseline to week 12. Response rate was calculated as the percentage of patients classified as responders.

Patient's Pain Score

The DLQI is a dermatology-specific health-related quality of life measure. The effect on a patient's life is as follows: 0-1=none; 2-5=small; 6-10=moderate; 11-20=very large; and 21-30=extremely large. Responders were defined as those who achieved a 50% improvement in the DLQI score.
Response rates were calculated as the percentage of participants achieving a response.

Dermatology Life Quality Index Score (DLQI)

Eligibility Assessment

12 Week Treatment Period

18-Week Post Treatment Assessment

Jennifer Goldfarb

Hidradenitis Suppurativa

etanercept 50 mg/week subcutaneous injection

spondylitis/headache

Yoga for Chronic Chikungunya

Inflammatory Back Pain and Gluten Free Diet

Assessment of Central Pain in Patients Who Undergo Spinal Surgery and Influence in Surgery Outcome

Etanercept for Treatment of Hidradenitis

Baz done ki pi konplè remèd fèy medsin te apiye nan syans